Research and Markets: Commercial Insight: Antidiabetics in Australia - Reimbursement Status Shapes Novel Classes (Business Wire)

11 November 2009 Last updated : 11 November 2009 BonTrade

DUBLIN----Research and Markets has announced the addition of the Commercial Insight: Antidiabetics in Australia - Reimbursement Status Shapes Novel Classes report to their offering.

Categories
General News

Leave a Reply

Previous article
Oil rises slightly, market eyes dollar, China (Reuters)
11 November 2009
Next article
International Wire Announces Third Quarter and First Nine Months 2009 Results (Business Wire)
11 November 2009